User: Guest  Login
Document type:
English Abstract; Journal Article
Author(s):
Miller, Kurt; Bergmann, Lothar; Doehn, Christian; Gschwend, Jürgen E; Kuczyk, Markus A
Title:
[Interdisciplinary recommendations for the treatment of metastatic renal cell carcinoma].
Abstract:
Due to novel therapies, the prognosis of patients with metastatic renal cell carcinoma has improved significantly. A median overall survival of more than two years is a realistic goal. Immunotherapies with checkpoint inhibitors are new first-line and second-line options. Sunitinib, Pazopanib, Tivozanib and the combination of Bevacizumab + interferon alpha are approved for first-line therapy, regardless of the progression risk score. The use of both the combination Nivolumab + Ipilimumab and Cabo...     »
Journal title abbreviation:
Aktuelle Urol
Year:
2019
Fulltext / DOI:
doi:10.1055/a-0972-0914
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/31486061
Print-ISSN:
0001-7868
TUM Institution:
Urologische Klinik und Poliklinik
 BibTeX